User login
- /content/chmp-recommends-new-indication-obinutuzumab
- /hematology-oncology/article/185546/lymphoma-plasma-cell-disorders/chmp-recommends-new-indication
- /hematologytimes/article/185546/lymphoma-plasma-cell-disorders/chmp-recommends-new-indication
- /b-cell-lymphoma-icymi/article/185546/lymphoma-plasma-cell-disorders/chmp-recommends-new-indication